Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)

被引：0
|
作者：
Zaja, Francesco [1 ]
Volpetti, Stefano [1 ]
Chiappella, Annalisa [2 ]
Salvi, Flavia [3 ]
Carella, Angelo M. [4 ]
Ibatici, Adalberto [4 ]
Piccaluga, Pier Paolo [5 ]
Pileri, Stefano A. [5 ]
Rossi, Davide [6 ]
Zinzani, Pier Luigi [7 ]
Patti, Caterina [8 ]
Vitolo, Umberto [2 ]
D'Arco, Alfonso [9 ]
Tucci, Alessandra [10 ,11 ]
Franceschetti, Silvia [12 ]
Evangelista, Andrea [13 ]
Lenti, Valentina [14 ]
Fanin, Renato [1 ]
Levis, Alessandro [15 ]
机构：
[1] Univ Udine, Dipartimento Sci Med Sperimentali & Clin DISM, I-33100 Udine, Italy
[2] SC Ematol Azienda Osped Citta Salute & Sci, Turin, Italy
[3] AO SS Antonio & Biagio & C Arrigo, Alessandria, Italy
[4] IRCCS AOU San Martino IST, UOC Ematol 1, Genoa, Italy
[5] Univ Bologna, Dip Med Specialist Diagnost & Sperimentale, Bologna, Italy
[6] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Translat Med, Novara, Italy
[7] Ist Ematol & Oncol Med, Bologna, Italy
[8] Azienda Osped Riuniti Villa Sofia Cervello, Div Ematol, Palermo, Italy
[9] UO Oncoematol Polo Oncol, Nocera Pagani, Italy
[10] Spedali Civil Brescia, SC Ematol, I-25125 Brescia, Italy
[11] Spedali Civil Brescia, Dipartimento Oncol Med, I-25125 Brescia, Italy
[12] Univ Piemonte Orientale Amedeo Avogadro, Div Ematol, Dipartimento Med Traslaz, Novara, Italy
[13] Univ Turin, SCDU Epidemiol Tumori, Turin, Italy
[14] Segreteria Fdn Italiana Linfomi Onlus, Alessandria, Italy
[15] SC Ematol AO SS Antonio & Biagio, Alessandria, Italy
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients
    Lukenbill, Joshua
    Hill, Brian
    LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 293 - 300
  • [32] R-CHOP21 VS R-CHOP14 IN 1024 DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: RESULTS FROM A MULTICENTRE RETROSPECTIVE STUDY OF FONDAZIONE ITALIANA LINFOMI (FIL)
    Rigacci, L.
    Puccini, B.
    Cabras, M. Giuseppina
    Fabbri, A.
    Nassi, L.
    Musura-ca, G.
    Mamusa, A.
    Franceschetti, S.
    Orciuolo, E.
    Lucchesi, A.
    Finolezzi, E.
    Gandolfi, S.
    Chiappella, A.
    Spina, M.
    Pietrini, A.
    Dessi, D.
    Ghio, F.
    Fabbri, F.
    Di Rocco, A.
    Balzarotti, M.
    Gaidano, G.
    Martelli, M.
    Vitolo, U.
    Bosi, A.
    HAEMATOLOGICA, 2013, 98 : 130 - 130
  • [33] Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study
    Kirschey, Sebastian
    Flohr, Thomas
    Wolf, Hans H.
    Frickhofen, Norbert
    Gramatzki, Martin
    Link, Hartmut
    Basara, Nadezda
    Peter, Norma
    Meyer, Ralf G.
    Schmitz, Norbert
    Weidmann, Eckhart
    Banat, Andre
    Schulz, Andrea
    Kolbe, Karin
    Derigs, Guenter
    Theobald, Matthias
    Hess, Georg
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 824 - 834
  • [34] RITUXIMAB, LENALIDOMIDE AND BENDAMUSTINE AS SECOND LINE THERAPY IN PATIENTS WITH MANTLE CELL LYMPHOMA: A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI
    Zaja, F.
    Ferrero, S.
    Stelitano, C.
    Ferrari, A.
    Ladetto, M.
    Salvi, F.
    Arcari, A.
    Musuraca, G.
    Botto, B.
    Spina, M.
    Cellini, C.
    Mule, A.
    Liberati, A. M.
    Minotto, C.
    Pileri, S. A.
    Ceccarelli, M.
    Volpetti, S.
    Ferranti, A.
    Dandri, D.
    Fanin, R.
    HAEMATOLOGICA, 2015, 100 : 16 - 17
  • [35] Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Ohmachi, Ken
    Niitsu, Nozomi
    Uchida, Toshiki
    Kim, Seok Jin
    Ando, Kiyoshi
    Takahashi, Naoki
    Takahashi, Naoto
    Uike, Naokuni
    Eom, Hyeon Seok
    Chae, Yee Soo
    Terauchi, Takashi
    Tateishi, Ukihide
    Tatsumi, Mitsuaki
    Kim, Won Seog
    Tobinai, Kensei
    Suh, Cheolwon
    Ogura, Michinori
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) : 2103 - +
  • [36] A MULTICENTER PHASE II STUDY OF BENDAMUSTINE WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Kim, W. S.
    Ando, K.
    Niitsu, N.
    Ogura, M.
    Takahashi, N.
    Uike, N.
    Eom, H. Seok
    Chae, Y. S.
    Tobinai, K.
    Terauchi, T.
    Tateishi, U.
    Tatsumi, M.
    Suh, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [37] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Salles, Gilles
    Dlugosz-Danecka, Monika
    Ghesquieres, Herve
    Jurczak, Wojciech
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 455 - 463
  • [38] Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi
    Merli, Francesco
    Luminari, Stefano
    Rossi, Giuseppe
    Mammi, Caterina
    Marcheselli, Luigi
    Ferrari, Angela
    Spina, Michele
    Tucci, Alessandra
    Stelitano, Caterina
    Capodanno, Isabella
    Fragasso, Alberto
    Baldini, Luca
    Bottelli, Chiara
    Montechiarello, Elisa
    Fogazzi, Stefano
    Lamorgese, Cinzia
    Cavalli, Lara
    Federico, Massimo
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 38 - 43
  • [39] B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)
    Balzarotti, Monica
    Brusamolino, Ercole
    Angelucci, Emanuele
    Carella, Angelo Michele
    Vitolo, Umberto
    Russo, Eleonora
    Congiu, Angelagiovanna
    Gotti, Manuel
    Massidda, Stefania
    Botto, Barbara
    Annechini, Giorgia
    Spina, Michele
    Re, Alessandro
    Zilioli, Vittorio Ruggero
    Merli, Francesco
    Salvi, Flavia
    Stelitano, Caterina
    Bonfichi, Maurizio
    Rodari, Marcello
    Murru, Roberta
    Magagnoli, Massimo
    Anastasia, Antonella
    Mazza, Rita
    Giordano, Laura
    Santoro, Armando
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2375 - 2381
  • [40] Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Yuan, Xianggui
    Li, Xian
    Huang, Yurong
    Jin, Xueli
    Liu, Hui
    Zhao, Aiqi
    Zhang, Weiping
    Qian, Wenbin
    Liang, Yun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345